AAAAAA

   
Results: 1-8 |
Results: 8
In vivo variability of TMA oxidation is partially mediated by polymorphisms of the FMO3 gene
Authors: Lambert, DM Mamer, OA Akerman, BR Choiniere, L Gaudet, D Hamet, P Treacy, EP
Citation: Dm. Lambert et al., In vivo variability of TMA oxidation is partially mediated by polymorphisms of the FMO3 gene, MOL GEN MET, 73(3), 2001, pp. 224-229
Characterization of phenylketonuria missense substitutions, distant from the phenylalanine hydroxylase active site, illustrates a paradigm for mechanism and potential modulation of phenotype, (vol 69, pg 101, 2000)
Authors: Waters, PJ Parniak, MA Akerman, BR Scriver, CR
Citation: Pj. Waters et al., Characterization of phenylketonuria missense substitutions, distant from the phenylalanine hydroxylase active site, illustrates a paradigm for mechanism and potential modulation of phenotype, (vol 69, pg 101, 2000), MOL GEN MET, 72(1), 2001, pp. 89-89
A novel deletion in the flavin-containing monooxygenase gene (FMO3) in a Greek patient with trimethylaminuria
Authors: Forrest, SM Knight, M Akerman, BR Cashman, JR Treacy, EP
Citation: Sm. Forrest et al., A novel deletion in the flavin-containing monooxygenase gene (FMO3) in a Greek patient with trimethylaminuria, PHARMACOGEN, 11(2), 2001, pp. 169-174
Characterization of phenylketonuria missense substitutions, distant from the phenylalanine hydroxylase active site, illustrates a paradigm for mechanism and potential modulation of phenotype
Authors: Waters, PJ Parniak, MA Akerman, BR Scriver, CR
Citation: Pj. Waters et al., Characterization of phenylketonuria missense substitutions, distant from the phenylalanine hydroxylase active site, illustrates a paradigm for mechanism and potential modulation of phenotype, MOL GEN MET, 69(2), 2000, pp. 101-110
Population-specific polymorphisms of the human FMO3 gene: Significance fordetoxication
Authors: Cashman, JR Akerman, BR Forrest, SM Treacy, EP
Citation: Jr. Cashman et al., Population-specific polymorphisms of the human FMO3 gene: Significance fordetoxication, DRUG META D, 28(2), 2000, pp. 169-173
Trimethylaminuria is caused by mutations of the FMO3 gene in a North American cohort
Authors: Akerman, BR Lemass, H Chow, LML Lambert, DM Greenberg, C Bibeau, C Mamer, OA Treacy, EP
Citation: Br. Akerman et al., Trimethylaminuria is caused by mutations of the FMO3 gene in a North American cohort, MOL GEN MET, 68(1), 1999, pp. 24-31
Two novel mutations of the FMO3 gene in a proband with trimethylaminuria
Authors: Akerman, BR Forrest, S Chow, L Youil, R Knight, M Treacy, EP
Citation: Br. Akerman et al., Two novel mutations of the FMO3 gene in a proband with trimethylaminuria, HUM MUTAT, 13(5), 1999, pp. 376-379
Missense mutations in the phenylalanine hydroxylase gene (PAH) can cause accelerated proteolytic turnover of PAH enzyme: A mechanism underlying phenylketonuria
Authors: Waters, PJ Parniak, MA Akerman, BR Jones, AO Scriver, CR
Citation: Pj. Waters et al., Missense mutations in the phenylalanine hydroxylase gene (PAH) can cause accelerated proteolytic turnover of PAH enzyme: A mechanism underlying phenylketonuria, J INH MET D, 22(3), 1999, pp. 208-212
Risultati: 1-8 |